Vitamin D is defined as the fat-soluble vitamin which is responsible for maintaining healthy bones & teeth. Although our body cannot produce Vitamin D, it is mainly obtained by the cutaneous production during sun exposure. The deficiency of vitamin D causes to bone pain & weakened muscles. Vitamin D therapy is provided to treat various conditions including rickets, muscle weakness, osteoporosis, skin diseases, and others.
The Global Vitamin D Therapy Market has explored some key dynamics which have a solid influence during this forecast period. This report studied the market trends, value trends, volume trends, and the pricing history of the market. Also, report covers different market driving factors, restraining factors, and opportunities to gain an insightful understanding of the market.
Get Free Sample Copy of This Report @ https://qualiketresearch.com/request-sample/Vitamin-D-Therapy-Market/request-sample
Key Players
Various key players are listed in this report such as Abbott Laboratories, Novartis International AG, Torrent Pharmaceuticals Ltd., Merck & Co., Inc., Sanofi, Pfizer, Inc., Cadila Healthcare Ltd., Sun Pharmaceutical Industries Ltd, Biotics Research Corporation, Alkem Laboratories Ltd, etc. Abbott Laboratories has a global distribution network & a good brand reputation among end users. The company’s strong presence as well as wide distribution channels across the world have helped it to maintain its leading position in the market. The company focusing on the mergers & acquisitions, with strategic alliances such as technology, licensing, to obtain an edge over competitors.
Market Taxonomy
By Route of Administration
- Oral
- Parenteral
By Application
- Rickets
- Muscle Weakness
- Osteoporosis
- Skin Diseases
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Get full Study @ https://qualiketresearch.com/reports-details/Vitamin-D-Therapy-Market
About Us
QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.
Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population.
On the other hand, the fortification of foods is likely to challenge the growth of this market.The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6%.
Market Dynamics+ Drivers+ Growing Awareness About Vitamin D Deficiency Among Consumers+ Presence of A Large Target Patient PopulationRequest for Free Sample Pages – https://www.marketsandmarkets.com/requestsampleNew.asp?id=32540026The oral route of administration is expected to register the largest share and highest CAGR during the forecast period.
This can be attributed to the ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity, increased patient compliance, and higher preference for the oral route.The market is segmented into osteoporosis, rickets, skin diseases, muscle weakness, autoimmune disorders, and other applications.
The osteoporosis segment is expected to register the highest growth during the forecast period.
This growth can be attributed to the increasing incidence of falls and fractures in senior adults due to the elevated levels of parathyroid hormones and the poor absorption of calcium from their diets.View Complete Press Releases – https://www.marketsandmarkets.com/PressReleases/vitamin-d-therapy.aspSome of the prominent players in the market are Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd (India).Abbott (US) is the largest player in the vitamin D therapy market.
In this report, Research Report Insights delivers key insights on the global Vitamin D Ingredients market in its published report, titled “Global Vitamin D Ingredients Market: Global Industry Analysis, size, sales and Forecast by 2026.” In terms of revenue, “The global market for vitamin D ingredients, which is presently valued over US$ 1.2 billion, will surge at a healthy CAGR of 11.1% and bring in revenues worth over US$ 3.5 billion by the end of 2026.”
Report For Sample with Table of Contents@ https://www.researchreportinsights.com/report/sample/110114815/Vitamin-D-Ingredients-Market
The market is segmented based on product type, source type, form type, application type and region. Based on product type, the market is sub-segmented into Vitamin D3 and Vitamin D2. Among all the material type segment, Vitamin D3 segment is expected to account for the highest market share, followed by Vitamin D2 segment over the forecast period. The Vitamin D2 material type segment is expected to register a significant CAGR of 8.16% during the forecast period in terms of value. The Vitamin D3 segment is projected to register the highest CAGR of 12.01% over the forecast period. The factors fuelling demand for Vitamin D Ingredients is the development in pharmaceutical industry and easy regulations for Vitamin D Ingredients globally.
To provide in-depth insights on the pattern of demand for Vitamin D Ingredients, the market is segmented on the basis of form such as Powder form, Resin form and Liquid form. The Powder form segment is projected to grow at a significant CAGR of 12.42% over the forecast period in terms of value. The market has been segmented by source type which includes fish, milk, Plants, Fruits & Vegetables, Eggs, Animals and Others (Microalgae, fungi, yeast, etc.). Fish segment is anticipated to be most attractive segment in terms of CAGR over the forecast period. Fish segment held a significant market share of 62.8% in 2016. The growing concern towards the decline in fish population issues create environmental concern which is expected to obstruct the growth of global Vitamin D Ingredients market. The market is segmented by application type which includes Pharmaceuticals, foods, beverages, cosmetics, Animal feeds & pet foods and others.
A key trend defining the market is that Vitamin D Ingredients service provider are shifting their focus towards plants sources due to increasing demand of vegetarian products. Manufacturers are shifting their focus towards Vitamin D2 and Vitamin D2 analog in order to grab a piece of the pie. Moreover, the Vitamin D Ingredients market is continuously shifting their focus towards make to order approach which not only provide effective protection to the product but removes the issues related to selling inventory.
Request For Report Discount@ https://www.researchreportinsights.com/report/discount/110114815/Vitamin-D-Ingredients-Market
Thriving Pharmaceutical Industry to Drive Growth of the Global Vitamin D Ingredients Market: RRI
This report assesses trends driving growth of each segment on the global level and offers potential takeaways that could prove substantially useful to Vitamin D Ingredients manufacturers looking to enter the market. The North America market dominated the Vitamin D Ingredients market, accounting for maximum revenue share of the market in 2016. Collectively, Western Europe and APEJ markets accounted for over 17.2% revenue share of the global Vitamin D Ingredients market in 2016. Among the emerging markets, Asia Pacific excluding Japan is estimated to exhibit a significant CAGR of 11.6% over the forecast period, followed by Middle East & Africa market, due to the growing Vitamin D deficiency among individuals.
Some of the key players in the global Vitamin D Ingredients market include BASF SE, Dishman Netherlands B.V., KONINKLIJKE DSM N.V., Zhejiang Garden Bio-Chemical High-Tech Company Limited, Schiff Nutrition International, Inc. (Reckitt Benckiser), Barr Pharmaceuticals (Teva Pharmaceuticals), GLAXOSMITHKLINE Plc., Fermenta Biotech Ltd, Lycored Limited and Polymed Therapeutics. In this report, we have discussed individual strategies followed by these companies in terms of enhancing their product portfolio, creating new marketing techniques, mergers and acquisitions. The ‘Competitive Landscape’ is included to provide report audiences with a dashboard view and company share collectively.
Report Analysis@ https://www.researchreportinsights.com/report/rd/110114815/Vitamin-D-Ingredients-Market
